Your browser doesn't support javascript.
loading
Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg.
Yang, Xiaoan; Zhang, Ka; Xu, Qihuan; Shu, Xin; Mo, Zhishuo; Xie, Dongying; Gao, Zhiliang; Deng, Hong.
Afiliação
  • Yang X; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Zhang K; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Xu Q; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Shu X; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Mo Z; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Xie D; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Gao Z; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Deng H; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Front Immunol ; 13: 997608, 2022.
Article em En | MEDLINE | ID: mdl-36148219

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article